Add Row 
Add 
GoodRx Welcomes New CFO, Christopher McGinnis
In a significant change for GoodRx, Christopher McGinnis has assumed the role of Chief Financial Officer this week. This move comes shortly after the company appointed its new CEO, Wendy Barnes. McGinnis is not new to the industry; he previously served as CEO of CitizensRx, showcasing a strong background in pharmacy benefit management.
A Transition in Leadership
McGinnis takes over from Karsten Voermann, who resigned for personal reasons after leading GoodRx's financial operations since 2020. During the transition, chief accounting officer Romin Nabiey stepped in as interim CFO. This restructuring aligns with a strategic pivot within GoodRx following the departure of its co-founders as co-CEOs last year.
Business Resilience Amidst Changes
Despite a decrease in stock price at the start of 2024, GoodRx remains resilient, posting notable revenue growth. In the third quarter, the company reported $195.3 million in revenue, marking more than an 8% year-over-year increase and a return to net income with profits of nearly $4 million — a turnaround from the previous year's losses.
The Future Outlook for GoodRx
With McGinnis at the financial helm and Barnes leading the charge, GoodRx is poised to bolster its market position. Their upcoming fourth-quarter earnings report, expected on February 27, will provide further insight into how their strategic changes are impacting the business.
Add Row 
Add 
Write A Comment